Lexicon Pharmaceuticals (LXRX) Payables: 2009-2012
Historic Payables for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $4.3 million.
- Lexicon Pharmaceuticals' Payables fell 22.08% to $4.3 million in Q3 2012 from the same period last year, while for Sep 2012 it was $20.3 million, marking a year-over-year increase of 13.72%. This contributed to the annual value of $6.0 million for FY2011, which is 91.26% up from last year.
- Per Lexicon Pharmaceuticals' latest filing, its Payables stood at $4.3 million for Q3 2012, which was down 5.96% from $4.6 million recorded in Q2 2012.
- Lexicon Pharmaceuticals' 5-year Payables high stood at $6.0 million for Q4 2011, and its period low was $3.1 million during Q1 2009.
- Over the past 3 years, Lexicon Pharmaceuticals' median Payables value was $4.6 million (recorded in 2012), while the average stood at $4.5 million.
- Its Payables has fluctuated over the past 5 years, first tumbled by 46.63% in 2010, then soared by 91.26% in 2011.
- Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Payables stood at $5.9 million in 2009, then tumbled by 46.63% to $3.2 million in 2010, then skyrocketed by 91.26% to $6.0 million in 2011, then decreased by 22.08% to $4.3 million in 2012.
- Its Payables was $4.3 million in Q3 2012, compared to $4.6 million in Q2 2012 and $5.3 million in Q1 2012.